淋巴细胞-话题@MedSci

#淋巴细胞#

495篇内容 | 3357人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1302445, encodeId=c6081302445ce, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=NEJM Evid：固定疗程的伊布替尼联合维奈克拉（Ibr+Ven）一线治疗慢性淋巴细胞白血病结果公布（GLOW研究）, objectType=article, longId=731593, objectId=2592e3159385, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2592e3159385, replyNumber=0, likeNumber=66, createdTime=2022-07-09, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2592e3159385, moduleTitle=NEJM Evid：固定疗程的伊布替尼联合维奈克拉（Ibr+Ven）一线治疗慢性淋巴细胞白血病结果公布（GLOW研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2592e3159385)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302444, encodeId=7a7613024448d, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=【即将直播】竺晓凡教授：儿童急性淋巴细胞白血病的诊治与并发症处理原则, objectType=article, longId=730353, objectId=76d9e3035375, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=76d9e3035375, replyNumber=0, likeNumber=40, createdTime=2022-06-25, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=76d9e3035375, moduleTitle=【即将直播】竺晓凡教授：儿童急性淋巴细胞白血病的诊治与并发症处理原则, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=76d9e3035375)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302443, encodeId=a53013024438d, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=ASCO 2022 | 慢性淋巴细胞白血病一线疗法：Calquence联合奥妥珠单抗持续生存获益：5年生存率达到90%！, objectType=article, longId=728833, objectId=026ae2883362, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=026ae2883362, replyNumber=0, likeNumber=36, createdTime=2022-06-09, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=026ae2883362, moduleTitle=ASCO 2022 | 慢性淋巴细胞白血病一线疗法：Calquence联合奥妥珠单抗持续生存获益：5年生存率达到90%！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=026ae2883362)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302440, encodeId=af651302440a3, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=JAHA：主动脉瓣置换术患者中性粒细胞与淋巴细胞比值的临床意义, objectType=article, longId=728646, objectId=c6fae28646dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c6fae28646dc, replyNumber=0, likeNumber=65, createdTime=2022-06-06, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c6fae28646dc, moduleTitle=JAHA：主动脉瓣置换术患者中性粒细胞与淋巴细胞比值的临床意义, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c6fae28646dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302442, encodeId=8355130244206, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=Lancet Oncol：复发/难治性慢性淋巴细胞白血病采用维奈托克+依鲁替尼治疗的“开关”——最小残留病灶, objectType=article, longId=728635, objectId=9e8ce2863581, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9e8ce2863581, replyNumber=0, likeNumber=0, createdTime=2022-06-06, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9e8ce2863581, moduleTitle=Lancet Oncol：复发/难治性慢性淋巴细胞白血病采用维奈托克+依鲁替尼治疗的“开关”——最小残留病灶, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9e8ce2863581)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302439, encodeId=ff0e1302439fc, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=Exp Hematol：血清 B 细胞成熟抗原是未经治疗的慢性淋巴细胞白血病的独立预后标志物 , objectType=article, longId=728558, objectId=0b3be2855881, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0b3be2855881, replyNumber=0, likeNumber=52, createdTime=2022-06-04, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0b3be2855881, moduleTitle=Exp Hematol：血清 B 细胞成熟抗原是未经治疗的慢性淋巴细胞白血病的独立预后标志物 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0b3be2855881)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302441, encodeId=67651302441a3, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=淋巴细胞增多背后的原因——大颗粒淋巴细胞, objectType=article, longId=728285, objectId=90e3e282852b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=90e3e282852b, replyNumber=0, likeNumber=36, createdTime=2022-06-01, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=90e3e282852b, moduleTitle=淋巴细胞增多背后的原因——大颗粒淋巴细胞, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=90e3e282852b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302438, encodeId=10fa1302438f5, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=【即将直播】慢性淋巴细胞白血病诊疗3天训练营|Day 1：慢性淋巴细胞白血病的诊断与评估, objectType=article, longId=728217, objectId=3f0de282176e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3f0de282176e, replyNumber=0, likeNumber=24, createdTime=2022-06-01, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3f0de282176e, moduleTitle=【即将直播】慢性淋巴细胞白血病诊疗3天训练营|Day 1：慢性淋巴细胞白血病的诊断与评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3f0de282176e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302437, encodeId=3b32130243ea6, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=Hematol Oncol：血清可溶性 CD23 水平是慢性淋巴细胞白血病首次治疗时间的独立预测因子, objectType=article, longId=727960, objectId=4d1fe27960c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4d1fe27960c3, replyNumber=0, likeNumber=49, createdTime=2022-05-28, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4d1fe27960c3, moduleTitle=Hematol Oncol：血清可溶性 CD23 水平是慢性淋巴细胞白血病首次治疗时间的独立预测因子, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4d1fe27960c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302436, encodeId=c34e130243606, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=同样的白细胞危急值，同样的淋巴细胞比例升高，看似相同，实则不然, objectType=article, longId=727878, objectId=c13ae2787837, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c13ae2787837, replyNumber=0, likeNumber=39, createdTime=2022-05-27, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c13ae2787837, moduleTitle=同样的白细胞危急值，同样的淋巴细胞比例升高，看似相同，实则不然, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c13ae2787837)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302434, encodeId=3ae4130243492, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=IJHS：美国急性淋巴细胞白血病的严重程度和死亡率住院：一项基于人群的研究, objectType=article, longId=727802, objectId=bf85e2780258, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bf85e2780258, replyNumber=0, likeNumber=37, createdTime=2022-05-26, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bf85e2780258, moduleTitle=IJHS：美国急性淋巴细胞白血病的严重程度和死亡率住院：一项基于人群的研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bf85e2780258)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302435, encodeId=7f4213024355a, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=一例颗粒性-急性T淋巴细胞白血病案例分享, objectType=article, longId=727764, objectId=2bbce27764e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2bbce27764e6, replyNumber=0, likeNumber=47, createdTime=2022-05-26, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2bbce27764e6, moduleTitle=一例颗粒性-急性T淋巴细胞白血病案例分享, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2bbce27764e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302433, encodeId=d9dd130243386, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=药明巨诺宣布倍诺达®针对儿童及年轻成人复发或难治性B细胞急性淋巴细胞白血病的临床试验申请获批, objectType=article, longId=724745, objectId=639fe24745ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=639fe24745ff, replyNumber=0, likeNumber=20, createdTime=2022-04-23, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=639fe24745ff, moduleTitle=药明巨诺宣布倍诺达®针对儿童及年轻成人复发或难治性B细胞急性淋巴细胞白血病的临床试验申请获批, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=639fe24745ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302432, encodeId=540f130243265, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=骨髓中仅见到0.5%的裂隙核淋巴细胞引起的反思, objectType=article, longId=724651, objectId=765de246517e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=765de246517e, replyNumber=0, likeNumber=48, createdTime=2022-04-22, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=765de246517e, moduleTitle=骨髓中仅见到0.5%的裂隙核淋巴细胞引起的反思, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=765de246517e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302430, encodeId=aa601302430e6, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=BJH：慢性淋巴细胞白血病对黑色素瘤结局的影响：一项回顾性病例对照研究, objectType=article, longId=302063, objectId=7e953020633b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7e953020633b, replyNumber=0, likeNumber=36, createdTime=2022-04-01, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7e953020633b, moduleTitle=BJH：慢性淋巴细胞白血病对黑色素瘤结局的影响：一项回顾性病例对照研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7e953020633b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302431, encodeId=10181302431fd, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=npj Parkinsons Dis：中性粒细胞和淋巴细胞比值，可预测多系统萎缩的生存期, objectType=article, longId=301908, objectId=3d3a3019081d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3d3a3019081d, replyNumber=0, likeNumber=51, createdTime=2022-03-30, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3d3a3019081d, moduleTitle=npj Parkinsons Dis：中性粒细胞和淋巴细胞比值，可预测多系统萎缩的生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3d3a3019081d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302428, encodeId=71ed13024283e, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=Haematol：甲氨蝶呤相关中枢神经毒性：急性淋巴细胞白血病治疗儿童的临床特征、危险因素和全基因组关联研究, objectType=article, longId=301765, objectId=2c41301e651f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2c41301e651f, replyNumber=0, likeNumber=42, createdTime=2022-03-28, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2c41301e651f, moduleTitle=Haematol：甲氨蝶呤相关中枢神经毒性：急性淋巴细胞白血病治疗儿童的临床特征、危险因素和全基因组关联研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2c41301e651f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302429, encodeId=69a713024291c, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle= Front Pharmacol：龙藤汤通过调节2型固有淋巴细胞促进胶原诱导关节炎小鼠滑膜炎症的消退, objectType=article, longId=301521, objectId=2b0d3015217c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2b0d3015217c, replyNumber=0, likeNumber=37, createdTime=2022-03-25, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2b0d3015217c, moduleTitle= Front Pharmacol：龙藤汤通过调节2型固有淋巴细胞促进胶原诱导关节炎小鼠滑膜炎症的消退, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2b0d3015217c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302427, encodeId=7831130242e05, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=AJTR：狼疮性肾炎患者外周血中性粒细胞/淋巴细胞和淋巴细胞/单核细胞比值与肾功能及预后的关系, objectType=article, longId=301230, objectId=6bd93012309f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6bd93012309f, replyNumber=0, likeNumber=46, createdTime=2022-03-21, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6bd93012309f, moduleTitle=AJTR：狼疮性肾炎患者外周血中性粒细胞/淋巴细胞和淋巴细胞/单核细胞比值与肾功能及预后的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6bd93012309f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302426, encodeId=a19f130242691, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=Blood：奥比妥珠单抗+依鲁替尼+维奈托克一线治疗高风险的慢性淋巴细胞白血病, objectType=article, longId=300815, objectId=6c63300815c7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6c63300815c7, replyNumber=0, likeNumber=37, createdTime=2022-03-16, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6c63300815c7, moduleTitle=Blood：奥比妥珠单抗+依鲁替尼+维奈托克一线治疗高风险的慢性淋巴细胞白血病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6c63300815c7)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

淋巴细胞

2020-05-29

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

NEJM Evid：固定疗程的伊布替尼联合维奈克拉（Ibr+Ven）一线治疗慢性淋巴细胞白血病结果公布（GLOW研究）

2022-07-09

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

【即将直播】竺晓凡教授：儿童急性淋巴细胞白血病的诊治与并发症处理原则

2022-06-25

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

ASCO 2022 | 慢性淋巴细胞白血病一线疗法：Calquence联合奥妥珠单抗持续生存获益：5年生存率达到90%！

2022-06-09

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

JAHA：主动脉瓣置换术患者中性粒细胞与淋巴细胞比值的临床意义

2022-06-06

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

Lancet Oncol：复发/难治性慢性淋巴细胞白血病采用维奈托克+依鲁替尼治疗的“开关”——最小残留病灶

2022-06-06

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

Exp Hematol：血清 B 细胞成熟抗原是未经治疗的慢性淋巴细胞白血病的独立预后标志物

2022-06-04

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

淋巴细胞增多背后的原因——大颗粒淋巴细胞

2022-06-01

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

【即将直播】慢性淋巴细胞白血病诊疗3天训练营|Day 1：慢性淋巴细胞白血病的诊断与评估

2022-06-01

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

Hematol Oncol：血清可溶性 CD23 水平是慢性淋巴细胞白血病首次治疗时间的独立预测因子

2022-05-28

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

同样的白细胞危急值，同样的淋巴细胞比例升高，看似相同，实则不然

2022-05-27

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

IJHS：美国急性淋巴细胞白血病的严重程度和死亡率住院：一项基于人群的研究

2022-05-26

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

一例颗粒性-急性T淋巴细胞白血病案例分享

2022-05-26

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

药明巨诺宣布倍诺达®针对儿童及年轻成人复发或难治性B细胞急性淋巴细胞白血病的临床试验申请获批

2022-04-23

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

骨髓中仅见到0.5%的裂隙核淋巴细胞引起的反思

2022-04-22

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

BJH：慢性淋巴细胞白血病对黑色素瘤结局的影响：一项回顾性病例对照研究

2022-04-01

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

npj Parkinsons Dis：中性粒细胞和淋巴细胞比值，可预测多系统萎缩的生存期

2022-03-30

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

Haematol：甲氨蝶呤相关中枢神经毒性：急性淋巴细胞白血病治疗儿童的临床特征、危险因素和全基因组关联研究

2022-03-28

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

Front Pharmacol：龙藤汤通过调节2型固有淋巴细胞促进胶原诱导关节炎小鼠滑膜炎症的消退

2022-03-25

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

AJTR：狼疮性肾炎患者外周血中性粒细胞/淋巴细胞和淋巴细胞/单核细胞比值与肾功能及预后的关系

2022-03-21

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

Blood：奥比妥珠单抗+依鲁替尼+维奈托克一线治疗高风险的慢性淋巴细胞白血病

2022-03-16

科室
- - 订阅+
  - 更多科室
工具
服务